|
|
|
Speakers: Calvin J. Cohen, MD Msc and Ian Frank, MD
Topic: Real Cases -
Which ARV Regimens do We Start With...As of Feb 2013
CRI Research Director Dr. Cal Cohen recently presented as part of an "HIV Grand Rounds" program on starting HIV medication regimens. Click on the link below to view the program.
About "HIV Grand Rounds": Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based.
|
Sponsorship |
This program is jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC.
|
Intended Audience
|
This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologists, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.
|
Commercial Support Acknowledgement
|
These activities are supported by educational grants from Gilead Sciences Medical Affairs and Janssen Pharmaceuticals, Inc.
|
Series Learning Objectives
|
Upon completion of the educational activity, participants should be able to
- List the important factors that play a role in ARV therapy success;
- Explain the role that drug adverse events, drug pharmacokinetics and patient adherence play in achieving ARV success and avoiding morbidity and mortality;
- Describe the important opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality
- Discuss the importance of individualizing the care of each HIV-positive patient
|
Faculty
|
Course Directors
Calvin J. Cohen, MD, MSc
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program Penn Center for AIDS Research Perelman School of Medicine at the
University of Pennsylvania Philadelphia, Pennsylvania
|
John G. Bartlett, MD
Chief, Division of Infectious Diseases Stanhope Bayne Jones Professor of Medicine Director, HIV Care Program Johns Hopkins School of Medicine Baltimore, Maryland
| Upcoming Faculty
Calvin J. Cohen, MD, MSc Research Director CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program Penn Center for AIDS Research Perelman School of Medicine at the
University of Pennsylvania Philadelphia, Pennsylvania
|
|
Accreditation and Designation Statements
|
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement:
The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
|
|
|
|
Community Research Initiative (CRI) is an independent, nonprofit, community-based organization in New England dedicated to HIV clinical research, treatment education, and financial assistance for approved drug treatments and health insurance coverage.
For more information about CRI, please visit our website or
|
|
|